Clinical Trial

Relationships Between Tenascin C, Smoking and Periodontal Status

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 26, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to determine if there is a relationship between different periodontal conditions (gingival healthy, stage 2 grade B, stage 2 grade C, stage 3 grade B, stage 3 grade C) and the levels of tenascin C, IL-1 beta, IL-4, and IL-6 in saliva samples from smokers and non-smokers. The main questions it aims to answer are: Is there a difference in the levels of tenascin C, IL-1 beta, IL-4, and IL-6 between smokers and non-smokers with different periodontal conditions? Do these biomarkers correlate with the severity and grade of periodontal disease? Researchers will compare the saliva samples from smokers and non-smokers across the different periodontal conditions to see if there are significant differences in the biomarker levels. Participants will: Provide saliva samples. Be categorized based on their smoking status and periodontal condition.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06523205
Lead Sponsor Necmettin Erbakan University
Conditions Periodontitis, Smoking, Periodontal Diseases
Enrollment 100 participants
Start Date 2024-08-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2024-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-26